NewAmsterdam Pharma GAAP EPS of -$0.14 beats by $0.30, revenue of $19.16M beats by $4.11M

Japan services PMI rises to 51.7 in October; composite growth slows to 5-month low

3M stock climbs to multi-year high on $7.35B 'forever chemicals' settlement

Stella-Jones outlines up to $100M in 3-year cost savings while targeting full Candiac run rate by end of Q1 2027

Viemed Healthcare reports mixed Q3 results; updates FY26 outlook